Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Conditions: Malignant Neoplasm of Liver Interventions: Drug: 68Ga-aGPC3-scFv/Fab Sponsors: Wuhan Union Hospital, China Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | China Health | COVID-19 | Hepatocellular Carcinoma | Hospitals | Liver | Liver Cancer | Research | Study | Urology & Nephrology